DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN ENDOTHELIAL DIFFERENTIATION, LYSOPHOSPHATIDIC ACID G-PROTEIN-COUPLED RECEPTOR 2 (EDG2)

Details for Australian Patent Application No. 2003278165 (hide)

Owner BAYER HEALTHCARE AG

Inventors BRUGGEMEIER, Ulf; SUMMER, Holger; GOLZ, Stefan

Pub. Number AU-A-2003278165

PCT Number PCT/EP03/12121

PCT Pub. Number WO2004/044580

Priority 02025100.5 13.11.02 EP

Filing date 31 October 2003

Wipo publication date 3 June 2004

International Classifications

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C07K 014/72 Peptides having more than 20 amino acids

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 02025100.5 13.11.02 EP

8 July 2004 Application Open to Public Inspection

  Published as AU-A-2003278165

28 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278166-Immunogenic composition

2003278164-DAILY MELATONIN DOSING UNITS